Pertussis in Argentina and France

被引:14
作者
Caro, Valerie
Bouchez, Valerie
Guiso, Nicole
Gatti, Blanca
Agosti, Maria Rosa
Ayala, Silvia E. Gonzalez
机构
[1] Natl Ctr Reference Whooping Cough & Other Bordete, CNRS, FRE 2849, Inst Pasteur,Mol Prevent & Therapy Human Dis Unit, F-75724 Paris 15, France
[2] Hosp Ninos Superiora Sor Maria Ludov, Microbiol Lab, La Plata, Argentina
[3] Hosp Ninos Superiora Sor Maria Ludov, Serv Enfermedades Infecciosas, La Plata, Argentina
关键词
Bordetella pertussis; pulsed-field gel electrophoresis; genotyping; Argentina; France; WHOLE-CELL VACCINE; BORDETELLA-PERTUSSIS; SEQUENCE VARIATION; EUROPEAN COUNTRIES; STRAINS; INFANTS; POLYMORPHISM; POPULATIONS; INFECTION; COVERAGE;
D O I
10.1016/j.vaccine.2006.08.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have studied the epidemiology of pertussis in two countries, Argentina and France, which have similar histories of long-term mass vaccination with a whole-cell vaccine. Both countries display a comparable epidemiology, with an increase of the incidence of the disease in non-vaccinated newborns. We used pulsed-field gel electrophoresis (PFGE) analysis and genotyping to compare Bordetella pertussis clinical isolates recovered in Argentina and France in 2001-2004. The majority of the isolates harbors prn2 allele and belongs to PFGE IV beta group. Isolates were found to be very similar genetically suggesting a common evolution of the disease in these two countries using the same vaccine. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4335 / 4339
页数:5
相关论文
共 33 条
[11]   Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years [J].
Elomaa, A ;
Advani, A ;
Donnelly, D ;
Antila, M ;
Mertsola, J ;
Hallander, H ;
He, QS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :3681-3687
[12]   Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production [J].
Fingermann, M ;
Fernández, J ;
Sisti, F ;
Rodríguez, ME ;
Gatti, B ;
Bottero, D ;
Graieb, A ;
Gaillard, ME ;
Ayala, SG ;
Mooi, FR ;
Lopardo, H ;
Hozbor, D .
VACCINE, 2006, 24 (17) :3513-3521
[13]  
Forsyth Kevin, 2005, Pediatr Infect Dis J, V24, pS69, DOI 10.1097/01.inf.0000160917.29723.03
[14]   SEX-DIFFERENCES IN MEASLES MORTALITY - A WORLD REVIEW [J].
GARENNE, M .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (03) :632-642
[15]   Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage [J].
Gilberg, S ;
Njamkepo, E ;
du Châtelet, IP ;
Partouche, H ;
Gueirard, P ;
Ghasarossian, C ;
Schlumberger, M ;
Guiso, N .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03) :415-418
[16]   Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? [J].
Godfroid, Fabrice ;
Denoel, Philippe ;
Poolman, Jan .
EXPERT REVIEW OF VACCINES, 2005, 4 (05) :757-778
[17]   Influence of vaccination coverage on pertussis transmission in France [J].
Grimprel, E ;
Baron, S ;
Lévy-Bruhl, D ;
Garnier, JM ;
N'jamkepo, E ;
Guiso, N ;
Bégué, P .
LANCET, 1999, 354 (9191) :1699-1700
[18]   Rapid diagnosis of pertussis in young infants: Comparison of culture, PCR, and infant's and mother's serology [J].
Grimprel, E ;
Njamkepo, E ;
Begue, P ;
Guiso, N .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (06) :723-726
[19]   Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960 -: Efficiency of the DTwP vaccine-induced immunity against currently circulating B-pertussis isolates [J].
Gzyl, A ;
Augustynowicz, E ;
Gniadek, G ;
Rabczenko, D ;
Dulny, G ;
Slusarczyk, J .
VACCINE, 2004, 22 (17-18) :2122-2128
[20]   Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs [J].
Hallander, HO ;
Advani, A ;
Donnelly, D ;
Gustafsson, L ;
Carlsson, RM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2856-2865